作者: Kate M Stampler , David O Holtz , Charles J Dunton
DOI: 10.2217/FON.11.55
关键词:
摘要: The management of ovarian cancer is not only multifactorial, but also patient-specific. Different treatment modalities lead to varying levels toxicity and individual patient responses, necessitating a personalized approach each plan. Surgical along with first-line salvage chemotherapies, are standard recent innovations in chemotherapy delivery innovative therapy mechanism action reviewed this article. Extensive experience has outlined algorithms for managing various toxicities. focus may ultimately point towards palliative care clinicians must be comfortable well versed addressing important option. Overall, requires multi-faceted approach, keeping the patients' overall health, curative goals well-being at forefront. It nearly impossible detail exact plans every possible patient; formulating should based on evidence clinician experience, all part art medicine. objective article highlight most frequently encountered limiting toxicities current therapies epithelial cancer.